It’s Time To Focus On The Long Run With Editas Medicine Inc (EDIT) stock

The price of Editas Medicine Inc (NASDAQ: EDIT) closed at $7.72 in the last session, down -5.04% from day before closing price of $8.13. In other words, the price has decreased by -$0.41 from its previous closing price. On the day, 2317404 shares were traded. EDIT stock price reached its highest trading level at $8.12 during the session, while it also had its lowest trading level at $7.70.

Ratios:

We take a closer look at EDIT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.39 and its Current Ratio is at 5.39. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.07.

On October 18, 2023, JP Morgan Upgraded its rating to Neutral which previously was Underweight but kept the price unchanged to $8.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 05 ’24 when O’Neill Gilmore Neil sold 77,824 shares for $9.42 per share. The transaction valued at 732,884 led to the insider holds 327,470 shares of the business.

Mei Baisong sold 20,327 shares of EDIT for $191,425 on Mar 04 ’24. The SVP, CHIEF MEDICAL OFFICER now owns 141,543 shares after completing the transaction at $9.42 per share. On Dec 05 ’23, another insider, Eaton Bruce, who serves as the EVP, CBO AND CTO of the company, sold 103 shares for $10.90 each. As a result, the insider received 1,122 and left with 74,791 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EDIT now has a Market Capitalization of 665.15M and an Enterprise Value of 378.57M. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.08 while its Price-to-Book (P/B) ratio in mrq is 1.81. Its current Enterprise Value per Revenue stands at 4.85 whereas that against EBITDA is -2.32.

Stock Price History:

Over the past 52 weeks, EDIT has reached a high of $11.91, while it has fallen to a 52-week low of $6.08. The 50-Day Moving Average of the stock is 8.35, while the 200-Day Moving Average is calculated to be 8.66.

Shares Statistics:

According to the various share statistics, EDIT traded on average about 1.86M shares per day over the past 3-months and 2.33M shares per day over the past 10 days. A total of 81.77M shares are outstanding, with a floating share count of 80.82M. Insiders hold about 1.22% of the company’s shares, while institutions hold 73.22% stake in the company. Shares short for EDIT as of Feb 29, 2024 were 13.52M with a Short Ratio of 7.26, compared to 12.21M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 16.52% and a Short% of Float of 23.22%.

Earnings Estimates

The company has 14 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.67 for the current quarter, with a high estimate of -$0.44 and a low estimate of -$1.09, while EPS last year was -$0.71. The consensus estimate for the next quarter is -$0.67, with high estimates of -$0.46 and low estimates of -$1.11.

Analysts are recommending an EPS of between -$1.84 and -$3.83 for the fiscal current year, implying an average EPS of -$2.66. EPS for the following year is -$2.74, with 15 analysts recommending between -$1.73 and -$4.51.

Most Popular

[the_ad id="945"]